Forum Topic News
  • Conversation: Neon Therapeutics, Translate Bio Join the Ranks of IPO Hopefuls

    • June 7, 2018 1:03 PM BST
    • Neon Therapeutics, Translate Bio Join the Ranks of IPO Hopefuls

      Xconomy Boston —
      At this rate, 2018 could be a record-breaking year for biotech IPOs. Two more Boston-area companies filed their IPO plans late last week. Neon Therapeutics is developing personalized cancer vaccines, one of which is in Phase 1 clinical testing. Translate Bio is a messenger RNA (mRNA) company that started human testing just last month.
      Neon and Translate each set a preliminary $115 million target for their respective IPOs, but that number is likely to change after the companies set their share price. Cambridge, MA-based Neon plans to list on the Nasdaq under the symbol “NTGN.” Translate, headquartered in Lexington, MA, has applied for a Nasdaq listing under the symbol “TBIO.”
      Read more: https://www.xconomy.com/boston/2018/06/04/neon-therapeutics-translate-bio-join-the-ranks-of-ipo-hopefuls/

Add Reputation

Do you want to add reputation for this member by this post?

or cancel